Dapagliflozin

7 FDA Decisions You Can't Afford to Ignore in Q4
Motley Fool
Sat, 10/15/11 - 11:39 am
Bristol-Myers Squibb
Dapagliflozin
BioSante
Bio-T-Gel
Regeneron
Eylea
Transcept
Intermezzo
Incyte
ruxolitinib
Antares
Anturol
FDA to Respond to Bristol-Myers Drug
Yahoo/Zacks.com
Wed, 10/5/11 - 09:58 am
FDA
Bristol-Myers Squibb
Dapagliflozin
diabetes
AstraZeneca
Dapagliflozin And Libigel Lead 4 October Healthcare Catalysts
Seeking Alpha
Tue, 10/4/11 - 11:23 am
LibiGel
Dapagliflozin
Antares
AstraZeneca
BioSante
Bristol-Myers Squibb
Teva Pharmaceuticals
Pacira
Biotech Calendar: Key Dates for October
TheStreet.com
Mon, 10/3/11 - 11:13 am
biotech
flurosorafenib
ONYX Pharmaceuticals
Bayer
Rigel
Teva Pharmaceuticals
Biogen Idec
BG-12
Heplisav
Amgen
Dynavax
Pacira
Bristol-Myers Squibb
Dapagliflozin
EXPAREL
cabozantinib
Exelixis
Biotech Calendar: 2011-12 FDA Drug Approvals
TheStreet.com
Thu, 08/11/11 - 12:37 pm
biotech
drug approvals
FDA
Eyelea
Regeneron
Dendreon
Provenge
NuPathe
Zelrix
Adcetris
Seattle Genetics
Soliris
Alexion
Dapagliflozin
AstraZeneca
Bristol-Myers Squibb
EXPAREL
Pacira
Roche
Zelboraf
Iluvien
Alimera
Bio-T-Gel
Teva Pharmaceuticals
BioSante
Zevalin
Spectrum
ruxolitinib
Incyte
Novartis
Pfizer
crizotinib
Antares
Anturol
Bydureon
Amlyin
Eli Lilly
Alkermes
AZ-004
Alexza
Corlux
Corcept Therapeutics
Affymax
Takeda
peginesatide
Levadex
MAP Pharmaceuticals
As Dapagliflozin Receives Negative Vote, What's Next for Bristol Myers?
Seeking Alpha
Thu, 07/21/11 - 10:57 am
Bristol-Myers Squibb
Dapagliflozin
Pfizer
Eli Lilly
AstraZeneca
JNJ
Yervoy
Bristol, AstraZeneca Rebuffed by FDA Panel on Diabetes Drug
Bloomberg
Tue, 07/19/11 - 06:11 pm
FDA
AstraZeneca
diabetes
Bristol-Myers Squibb
Dapagliflozin
Regulatory "sword of Damocles" dangles over two big AZ drugs
Fierce Biotech
Tue, 07/19/11 - 01:14 pm
AstraZeneca
FDA
Brilinta
blood thinners
Dapagliflozin
Bristol-Myers Squibb
What's in Store for Bristol Myers Squibb at Dapagliflozin FDA Hearing
Seeking Alpha
Mon, 07/18/11 - 09:49 am
FDA
Dapagliflozin
Bristol-Myers Squibb
diabetes
advisory panels
FDA Cites Risks in Diabetes Drug
Motley Fool
Sun, 07/17/11 - 12:04 pm
AstraZeneca
Bristol-Myers Squibb
Dapagliflozin
diabetes
FDA Says Bristol-AstraZeneca Diabetes Drug May Cause Cancer
Bloomberg
Fri, 07/15/11 - 02:21 pm
FDA
diabetes
Bristol-Myers Squibb
AstraZeneca
Dapagliflozin
bladder cancer
Fate of Bristol Myers' Dapagliflozin Rests With an FDA Advisoy Committee
Seeking Alpha
Fri, 07/15/11 - 01:01 am
Bristol-Myers Squibb
Dapagliflozin
FDA
advisory panels
diabetes
3 Biotech Drugs With Promising Phase III Data, Moving Into FDA Review
Motley Fool
Fri, 07/1/11 - 09:44 am
FDA
Bristol-Myers Squibb
AstraZeneca
Pfizer
Incyte
Novartis
ruxolitinib
Apixaban
Dapagliflozin
Bristol-Myers, AstraZeneca Diabetes Drug Shows Bladder, Breast Cancer Risk
Bloomberg
Sun, 06/26/11 - 12:09 pm
Bristol-Myers Squibb
AstraZeneca
Dapagliflozin
diabetes
Bristol-Myers Diabetes Drug Draws Scrutiny After Avandia, Actos
Bloomberg
Thu, 06/23/11 - 09:12 am
Avandia
diabetes
Bristol-Myers Squibb
Actos
Takeda
AstraZeneca
Dapagliflozin
FDA accepts application for Astra diabetes drug
Yahoo/AP
Tue, 03/8/11 - 09:36 am
FDA
diabetes
Bristol-Myers Squibb
AstraZeneca
Dapagliflozin
AstraZeneca, Bristol Myers Move Forward With Diabetes Drug
Minyanville
Sat, 09/25/10 - 12:11 pm
AstraZeneca
Bristol-Myers Squibb
Dapagliflozin
diabetes
Dapagliflozin: Potential Blockbuster, No Me-Too About It
Motley Fool
Tue, 09/21/10 - 11:13 am
diabetes
Bristol-Myers Squibb
Dapagliflozin
AstraZeneca
Bristol-Myers and AstraZeneca say dapagliflozin helped diabetes patients reduce blood sugar
Yahoo/AP
Mon, 09/20/10 - 11:35 am
Bristol-Myers Squibb
AstraZeneca
Dapagliflozin
diabetes
Bristol-Myers Has New CFO, Strong Pipeline
Investors Business Daily
Sat, 04/10/10 - 12:35 pm
Bristol-Myers Squibb
Dapagliflozin
coagulants

Pages